Marija Sollner
University of Ljubljana
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Marija Sollner.
Inflammation Research | 1993
Marija Sollner; Vladimir Kotnik; Pečar; A. Štalc; Saša Simčič; L. Povšič; B. Herzog-Wraber; L. Klampfer; Alojz Ihan; P. Grosman
The synthesis and some immunological characteristics of a new desmuramyl dipeptide 7-oxooctanoyl-l-alanyl-d-isoglutamine (LK-409) are presented. The effects of this compound were compared with those ofN-acteylmuramyl-l-alanyl-d-isoglutamine (MDP). The influence of LK-409 on the number of B and T cells in spleen and the number of peritoneal macrophages was studied; Jernes plaque forming cells assay was performed to monitor the effect of B cell differentiation. The blast transformation of T cells stimulated with concanavalin A was used to detect the influences on T lymphocytes. The activation of macrophages was studied as well. In contrast to MDP, LK-409 was apyrogenic in the doses applied but had similar immunomodulatory properties. Tested immunological properties and the absence of pyrogenicity and low toxicity make LK-409 a candidate for an immunomodulatory drug and a model molecule suitable for studying and understanding the dual activity of the MDP and its analogues.
Pflügers Archiv: European Journal of Physiology | 2000
Saša Simčič; Branka Wraber; Marija Sollner; Uroš Urleb; Stanislav Gobec
Abstract Some synthetic analogues of the immuno-modulatory agent muramyl dipeptide (MDP), i.e. phthalimido- (LK-511, LK-413, LK-512, LK-423, LK-508), adamantyl- (LK-415, LK-517), 7-oxoaIkyl-(LK-409) desmuramylpeptides were assessed for the tumour necrosis factor (TNF) inducing activity and the ability to modulate TNF production in in vitro phorbol 12-myristate 13-acetate (PMA) & ionomycin stimulated cultures of human peripheral blood mononuclear cells. A kinetic study over a 40-hour period indicated that desmuramyldipeptides were weak TNF inducers compared to romurtide, PMA & ionomycin or lipopolysaccharide. By contrast, they showed the potential to up- or down-regulate the production of TNF evoked by PMA & ionomycin, which was strongly dependent on the time of the stimulation. After 4h of stimulation, the TNF secretion was augmented by LK-508, LK-409 and LK-511, after 18 h by LK-409 and LK-423, and after 40 h by LK-423, LK-511, LK-415 and LK-512. However, LK-517 and LK-512 inhibited the secretion of TNF after the 18-h period.
Archiv Der Pharmazie | 1995
Uroš Urleb; Ales Krbavcic; Marija Sollner; Danijel Kikelj; Slavko Pečar
Archive | 1994
Slavko Pečar; Marija Sollner; Uroš Urleb; Danijel Kikelj; Gasper Marc; Ales Krbavcic; Vlado Dr. Kotnik; Branka Wraber-Herzog; Saša Simčič; Alojz Ihan; Lidija Klamfer; Lucka Povsic; Zdravko Prof. Dr. Kopitar; Anton Štalc
Archive | 1991
Slavko Pečar; Danijel Kikelj; Uroš Urleb; Marija Sollner; Gasper Marc; Ales Krbavcic; Vlado Dr. Kotnik; Branka Wraber-Herzog; Sasa Simcie; Alojz Than; Lidija Klamfer; Lucka Povsic; Zdravko Kopitar; Anton Štalc
Archive | 1991
Alojz Ihan; Danijel Kikelj; Lidija Klamfer; Zdravko Prof. Dr. Kopitar; Vlado Dr. Kotnik; Ales Krbavcic; Gasper Marc; Slavko Pečar; Lucka Povsic; Saša Simčič; Marija Sollner; Anton Štalc; Uroš Urleb; Branka Wraber-Herzog
Arkivoc | 2001
Franc Tratar; Gasper Marc; Marija Sollner; Danijel Kikelj
Archive | 1991
Slavko Pečar; Danijel Kikelj; Uroš Urleb; Marija Sollner; Gasper Marc; Ales Krbavcic; Vlado Dr. Kotnik; Branka Wraber-Herzog; Saša Simčič; Alojz Ihan; Lidija Klamfer; Lucka Povsic; Zdravko Prof. Dr. Kopitar; Anton Štalc
Acta Pharmaceutica | 2001
Marija Sollner; Anton Štalc; Saga Simcic; Branka Wraber; Vladimir Kotnik; Lucka Povsic; Uroš Urleb
Archive | 1996
Slavko Pečar; Danijel Kikelj; Uroš Urleb; Marija Sollner; Gasper Marc; Ales Krbavcic; Vlado Dr. Kotnik; Branka Wraber-Herzog; Saša Simčič; Alojz Ihan; Lidija Klamfer; Lucka Povsic; Zdravko Prof. Dr. Kopitar; Anton Štalc